Drug interactions between Claritin and methylprednisolone
Interactions between your drugs
There were no interactions found in our database between Claritin and methylprednisolone - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
- Claritin is in the drug class antihistamines.
- Claritin is used to treat the following conditions:
- Methylprednisolone is a member of the drug class glucocorticoids.
- Methylprednisolone is used to treat the following conditions:
- Adrenogenital Syndrome
- Allergic Rhinitis
- Asthma, acute
- Asthma, Maintenance
- Atopic Dermatitis
- Dermatologic Lesion
- Gout, Acute
- Inflammatory Conditions
- Multiple Sclerosis
- Plaque Psoriasis
- Rheumatoid Arthritis
- Transverse Myelitis
- Ulcerative Colitis, Active
Drug and food interactions
Applies to: methylprednisolone
Grapefruit juice may increase the blood levels and effects of certain medications such as methylPREDNISolone. You may want to limit your consumption of grapefruit and grapefruit juice during treatment with methylPREDNISolone. However, if you have been regularly consuming grapefruit or grapefruit juice with methylPREDNISolone, do not alter the amounts of these products in your diet without first talking to your doctor or other healthcare professional. Contact your doctor if your condition changes or you experience increased side effects. Orange juice is not expected to interact.
Applies to: Claritin (loratadine)
Consumer information for this minor interaction is not currently available. Some minor drug interactions may not be clinically relevant in all patients. Minor drug interactions do not usually cause harm or require a change in therapy. However, your healthcare provider can determine if adjustments to your medications are needed.
For clinical details see professional interaction data.
Therapeutic duplication warnings
No therapeutic duplications were found for your selected drugs.
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No information available.|
Do not stop taking any medications without consulting your healthcare provider.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.